Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.
1 other identifier
observational
200
0 countries
N/A
Brief Summary
Determine the frequency of psychiatric and neurological comorbidities in children and adolescence diagnosed with ADHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2021
CompletedFirst Posted
Study publicly available on registry
July 1, 2021
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFebruary 3, 2022
February 1, 2022
5 months
June 23, 2021
February 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine psychiatric comorbidities in children and adolescents with ADHD using Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid).
Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid): is structured clinical diagnostic interview designed to assess the presence of current ICD-10 and DSM-IV psychiatric disorders in children and adolescents age 6-17 years
baseline
Secondary Outcomes (1)
determinate presence of soft neurological sign in children and adolescents with ADHD using Cambridge neurological inventory.
baseline
Study Arms (2)
case group
100 ADHD patients; will be taken from outpatient clinic of child and adolescence psychiatry of Assiut university hospitals.
control group
100 normal children; they will be selected from neurology clinic complaining from minor neurological complaint e.g : headache, will match with the case group for age, sex and educational level.
Interventions
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .
Eligibility Criteria
Case group will include 100 ADHD patients; will be taken from outpatient clinic of child and adolescence psychiatry of Assiut university hospitals. Control group will include 100 normal children; they will be selected from neurology clinic complaining from minor neurological complaint e.g : headache, will match with the case group for age, sex and educational level.
You may qualify if:
- Age: 6-17 years.
- Sex: both sexes will be included in the study.
- IQ≥70.
You may not qualify if:
- Age: less than 6 years or more than 17 years.
- IQ\<70.
- Patients with major neurological deficits, cerebral palsy and uncontrolled epilepsy.
- Patients with major psychiatric disorders e.g schizophrenia spectrum disorder.
- Patient who refusing to participate in the study or their caregiver refusing to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Gillberg C, Gillberg IC, Rasmussen P, Kadesjo B, Soderstrom H, Rastam M, Johnson M, Rothenberger A, Niklasson L. Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I80-92. doi: 10.1007/s00787-004-1008-4.
PMID: 15322959BACKGROUNDFaraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Aug 6;1:15020. doi: 10.1038/nrdp.2015.20.
PMID: 27189265BACKGROUNDJensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38. doi: 10.1007/s12402-014-0142-1. Epub 2014 Jun 19.
PMID: 24942707BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Ahmed Abdelbaky Abd elrahman, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
June 23, 2021
First Posted
July 1, 2021
Study Start
March 1, 2022
Primary Completion
August 1, 2022
Study Completion
October 1, 2022
Last Updated
February 3, 2022
Record last verified: 2022-02